New approaches to Helicobacter pylori infection in children

B D Gold1

  • 1Division of Pediatric Gastroenterology and Nutrition, Department of Pediatrics, Emory University School of Medicine, 2040 Ridgewood Drive NE, Atlanta, GA 30322, USA. ben_gold@oz.ped.emory.edu

Insights

Childhood Helicobacter pylori infection guidelines are available for diagnosis and treatment. Further research is needed to understand its natural history and develop prevention strategies for H. pylori in children.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Microbiology

Background:

  • Helicobacter pylori (H. pylori) infection is common in childhood.
  • Published guidelines now exist for diagnosing and treating H. pylori in children.
  • Diseases linked to H. pylori include gastritis, ulcers, MALT lymphoma, and gastric cancer.

Purpose of the Study:

  • To summarize current evidence-based guidelines for H. pylori diagnosis and treatment in children.
  • To highlight areas needing further research, such as the natural history and prevention of childhood H. pylori infection.
  • To discuss the controversial associations between H. pylori and symptoms like abdominal pain and dyspepsia.

Main Methods:

  • Review of recent evidence-based guidelines for pediatric H. pylori infection.
  • Analysis of the established and controversial associations of H. pylori with gastrointestinal and extra-gastrointestinal diseases.
  • Discussion of diagnostic methods, including endoscopy with biopsies and ongoing validation of noninvasive tests.

Main Results:

  • Guidelines recommend H. pylori eradication for children with duodenal/gastric ulcers, gastric lymphoma, and atrophic gastritis.
  • The link between H. pylori and symptoms like recurrent abdominal pain and nonulcer dyspepsia in children remains unclear.
  • Causality is not sufficiently established for H. pylori's role in GERD or extra-GI conditions like coronary artery disease.

Conclusions:

  • Current guidelines provide a framework for managing H. pylori in children with specific conditions.
  • More research is essential to understand the natural progression of childhood H. pylori infections and to develop effective prevention and control measures.
  • Characterizing acquisition determinants and disease outcomes post-eradication is crucial for future strategies.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...